Cargando…
Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy
| Autores principales: | , , , , , , , , , , , , , |
|---|---|
| Formato: | Online Artículo Texto |
| Lenguaje: | English |
| Publicado: |
Fondazione Ferrata Storti
2023
|
| Materias: | |
| Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620560/ https://www.ncbi.nlm.nih.gov/pubmed/36861409 http://dx.doi.org/10.3324/haematol.2022.282677 |
| _version_ | 1785130231894376448 |
|---|---|
| author | Gangat, Naseema Ilyas, Rimal Johnson, Isla M. McCullough, Kristen Al-Kali, Aref Alkhateeb, Hassan B. Begna, Kebede H. Mangaonkar, Abhishek Litzow, Mark R Hogan, William Shah, Mithun Patnaik, Mrinal M. Pardanani, Animesh Tefferi, Ayalew |
| author_facet | Gangat, Naseema Ilyas, Rimal Johnson, Isla M. McCullough, Kristen Al-Kali, Aref Alkhateeb, Hassan B. Begna, Kebede H. Mangaonkar, Abhishek Litzow, Mark R Hogan, William Shah, Mithun Patnaik, Mrinal M. Pardanani, Animesh Tefferi, Ayalew |
| author_sort | Gangat, Naseema |
| collection | PubMed |
| description | |
| format | Online Article Text |
| id | pubmed-10620560 |
| institution | National Center for Biotechnology Information |
| language | English |
| publishDate | 2023 |
| publisher | Fondazione Ferrata Storti |
| record_format | MEDLINE/PubMed |
| spelling | pubmed-106205602023-11-03 Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy Gangat, Naseema Ilyas, Rimal Johnson, Isla M. McCullough, Kristen Al-Kali, Aref Alkhateeb, Hassan B. Begna, Kebede H. Mangaonkar, Abhishek Litzow, Mark R Hogan, William Shah, Mithun Patnaik, Mrinal M. Pardanani, Animesh Tefferi, Ayalew Haematologica Letter to the Editor Fondazione Ferrata Storti 2023-03-02 /pmc/articles/PMC10620560/ /pubmed/36861409 http://dx.doi.org/10.3324/haematol.2022.282677 Text en Copyright© 2023 Ferrata Storti Foundation https://creativecommons.org/licenses/by-nc/4.0/This article is distributed under the terms of the Creative Commons Attribution Noncommercial License (by-nc 4.0) which permits any noncommercial use, distribution, and reproduction in any medium, provided the original author(s) and source are credited. |
| spellingShingle | Letter to the Editor Gangat, Naseema Ilyas, Rimal Johnson, Isla M. McCullough, Kristen Al-Kali, Aref Alkhateeb, Hassan B. Begna, Kebede H. Mangaonkar, Abhishek Litzow, Mark R Hogan, William Shah, Mithun Patnaik, Mrinal M. Pardanani, Animesh Tefferi, Ayalew Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy |
| title | Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy |
| title_full | Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy |
| title_fullStr | Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy |
| title_full_unstemmed | Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy |
| title_short | Outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy |
| title_sort | outcome of patients with acute myeloid leukemia following failure of frontline venetoclax plus hypomethylating agent therapy |
| topic | Letter to the Editor |
| url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10620560/ https://www.ncbi.nlm.nih.gov/pubmed/36861409 http://dx.doi.org/10.3324/haematol.2022.282677 |
| work_keys_str_mv | AT gangatnaseema outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT ilyasrimal outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT johnsonislam outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT mcculloughkristen outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT alkaliaref outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT alkhateebhassanb outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT begnakebedeh outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT mangaonkarabhishek outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT litzowmarkr outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT hoganwilliam outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT shahmithun outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT patnaikmrinalm outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT pardananianimesh outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy AT tefferiayalew outcomeofpatientswithacutemyeloidleukemiafollowingfailureoffrontlinevenetoclaxplushypomethylatingagenttherapy |